Literature DB >> 17064299

Histopathological features of breast cancer in carriers of ATM gene variants.

R L Balleine1, R Murali, A M Bilous, G Farshid, P Waring, P Provan, K Byth, H Thorne, J A Kirk.   

Abstract

AIMS: Germline variants in the ataxia telangiectasia mutated (ATM) gene have been implicated in increased breast cancer risk. The aim of this study was to determine whether the histopathology of breast cancers occurring in ATM variant carriers is distinctive or resembles the described BRCA1 mutation-associated phenotype.
METHODS: The histopathological features of breast cancers occurring in ATM variant carriers from multiple-case breast cancer families were compared with matched controls. The test group included 21 cases of in situ and/or invasive cancer from carriers of either the IVS10-6T-->G, 2424V-->G or 1420L-->F ATM variants in the absence of BRCA1 or BRCA2 mutations. An additional four invasive cancers from carriers of a pathogenic BRCA1 mutation in the context of a familial ATM variant were also examined.
RESULTS: The histopathology of breast cancers in ATM variant-only carriers was not significantly different from controls and known features of BRCA1 mutation-associated cancer were rarely seen. In contrast, these features were prominent in the small group of cases with a pathogenic BRCA1 mutation.
CONCLUSIONS: Breast cancer occurring in carriers of ATM variants is not associated with distinctive histopathological features and does not resemble the tumour phenotype commonly observed in BRCA1 mutation carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064299     DOI: 10.1111/j.1365-2559.2006.02538.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

Review 1.  The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.

Authors:  Ana Cristina Vargas; Leonard Da Silva; Sunil R Lakhani
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 2.  Phenotype-genotype correlation in familial breast cancer.

Authors:  Ana Cristina Vargas; Jorge S Reis-Filho; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-12       Impact factor: 2.673

3.  Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

Authors:  Anne-Laure Renault; Noura Mebirouk; Laetitia Fuhrmann; Guillaume Bataillon; Eve Cavaciuti; Dorothée Le Gal; Elodie Girard; Tatiana Popova; Philippe La Rosa; Juana Beauvallet; Séverine Eon-Marchais; Marie-Gabrielle Dondon; Catherine Dubois d'Enghien; Anthony Laugé; Walid Chemlali; Virginie Raynal; Martine Labbé; Ivan Bièche; Sylvain Baulande; Jacques-Olivier Bay; Pascaline Berthet; Olivier Caron; Bruno Buecher; Laurence Faivre; Marc Fresnay; Marion Gauthier-Villars; Paul Gesta; Nicolas Janin; Sophie Lejeune; Christine Maugard; Sébastien Moutton; Laurence Venat-Bouvet; Hélène Zattara; Jean-Pierre Fricker; Laurence Gladieff; Isabelle Coupier; Georgia Chenevix-Trench; Janet Hall; Anne Vincent-Salomon; Dominique Stoppa-Lyonnet; Nadine Andrieu; Fabienne Lesueur
Journal:  Breast Cancer Res       Date:  2018-04-17       Impact factor: 6.466

Review 4.  First international workshop of the ATM and cancer risk group (4-5 December 2019).

Authors:  Fabienne Lesueur; Douglas F Easton; Anne-Laure Renault; Sean V Tavtigian; Jonine L Bernstein; Zsofia Kote-Jarai; Rosalind A Eeles; Dijana Plaseska-Karanfia; Lidia Feliubadaló; Banu Arun; Natalie Herold; Beatrix Versmold; Rita Katharina Schmutzler; Tú Nguyen-Dumont; Melissa C Southey; Leila Dorling; Alison M Dunning; Paola Ghiorzo; Bruna Samia Dalmasso; Eve Cavaciuti; Dorothée Le Gal; Nicholas J Roberts; Mev Dominguez-Valentin; Matti Rookus; Alexander M R Taylor; Alisa M Goldstein; David E Goldgar; Dominique Stoppa-Lyonnet; Nadine Andrieu
Journal:  Fam Cancer       Date:  2021-06-14       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.